Results 221 to 230 of about 5,999,713 (315)

"Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality. [PDF]

Cancer
Sedrak MS, Ramalingam SS, Sparano JA.
europepmc   +1 more source

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis. [PDF]

J Neurol
Muñoz-Vendrell A, Arroyo-Pereiro P, León I, Bau L, Matas E, Romero-Pinel L, Roca-Pereira S, Martínez-Yélamos A, Martínez-Yélamos S.   +8 more
europepmc   +1 more source

Maternal oxidative stress biomarkers across pregnancy in relation to fetal growth: evidence from the TIDES cohort. [PDF]

Am J Epidemiol
Baghsheikhi H, Trasande L, Manuel RSJ, Shahin S, Cajachagua-Torres KN, Duh-Leong C, Kannan K, Barrett ES, Bush NR, Nguyen RH, Swan SH, Sathyanarayana S, Stevens D, Ferguson KK, Cowell W.   +14 more
europepmc   +1 more source

International Stakeholder Guidance for Improving Informativeness of Randomized Clinical Trials.

JAMA Netw Open
Prowse SR, Brazzelli M, Green HR, Treweek S.   +3 more
europepmc   +1 more source